Unit
- Primary hemostasis: Platelet adhesion, activation, and aggregation form a platelet plug at the site of vascular injury. This process involves von Willebrand factor as a bridge between platelets and exposed collagen.
- Secondary hemostasis: The coagulation cascade amplifies the platelet plug through a series of enzymatic reactions, converting fibrinogen to fibrin and stabilizing the clot. The intrinsic and extrinsic pathways converge on a common pathway.
- Fibrinolysis: Plasminogen is converted to plasmin, which degrades fibrin clots to prevent excessive thrombosis and restore vessel patency. This balance is critical for normal hemostasis.
- Regulatory mechanisms: Natural anticoagulants such as antithrombin, protein C, and protein S inhibit coagulation factors to prevent uncontrolled clot formation. Tissue factor pathway inhibitor further regulates the extrinsic pathway.
- Endothelial role: Intact endothelium produces prostacyclin and nitric oxide to inhibit platelet activation. When injured, endothelial cells express tissue factor and release von Willebrand factor to initiate hemostasis.
- Platelet disorders: Quantitative (thrombocytopenia) or qualitative (dysfunction) platelet abnormalities can cause bleeding tendencies, often presenting with mucocutaneous bleeding and petechiae.
- Coagulation factor deficiencies: Deficiencies in factors VIII, IX, XI, and others lead to prolonged clotting times and specific bleeding patterns such as hemarthroses in hemophilia.
- Clinical significance: Understanding these mechanisms allows healthcare professionals to interpret laboratory tests, anticipate bleeding risks, and coordinate appropriate care for patients with coagulation disorders.
- Vitamin K dependent factors: Factors II, VII, IX, and X require vitamin K for carboxylation and functional activity. Warfarin inhibits this carboxylation, prolonging the prothrombin time and increasing bleeding risk. Deficiencies from malnutrition or liver disease produce similar effects. Knowledge of this pathway is essential for managing anticoagulation therapy and interpreting laboratory results.
- Common pathway and laboratory assessment: The common pathway includes factors X, V, II, and fibrinogen, ultimately forming a stable fibrin clot. Prothrombin time evaluates the extrinsic and common pathways, while activated partial thromboplastin time assesses the intrinsic and common pathways. Prolonged clotting times indicate deficiencies or inhibitors in the corresponding pathways, guiding diagnostic workup.
- Disseminated intravascular coagulation: DIC is a pathologic condition of widespread coagulation activation followed by consumption of platelets and clotting factors, leading to both thrombosis and hemorrhage. It commonly complicates sepsis, trauma, or malignancy. Diagnosis relies on prolonged PT/aPTT, thrombocytopenia, elevated D dimer, and low fibrinogen levels, requiring prompt multidisciplinary management.
- von Willebrand disease: This most common inherited bleeding disorder arises from quantitative or qualitative defects in von Willebrand factor, impairing platelet adhesion. Symptoms include mucocutaneous bleeding, easy bruising, menorrhagia, and prolonged bleeding after surgery or dental procedures. Treatment options include desmopressin to release stored VWF or factor concentrates containing both VWF and factor VIII.
Scope of Practice
Role: Healthcare Coordinator in Coagulation Clinic
Within scope:
- Understanding and explaining basic hemostasis to patients using lay terms
- Coordinating laboratory testing and sample handling for coagulation assays
- Documenting patient bleeding histories and family patterns
- Assisting in scheduling consultations with hematologists
- Educating patients on signs of abnormal bleeding or clotting
Outside scope:
- Interpreting complex coagulation results without provider oversight
- Prescribing anticoagulant or hemostatic medications
- Diagnosing specific coagulation disorders
- Performing diagnostic procedures such as bleeding time tests
- Modifying treatment plans based on lab results
Quick Revision
- Hemostasis involves primary (platelet) and secondary (coagulation cascade) phases, followed by fibrinolysis.
- Regulatory proteins like antithrombin and protein C maintain balance.
- Disorders can arise from platelet or coagulation factor abnormalities.
- Clinicians must recognize scope boundaries when managing coagulation patients.